1
0
6
2
A N N U A L
R E P O R T
Letter to Shareholders
This has been a year of contrasts for IKONICS. Sales of Advanced Material Solutions (AMS), our aerospace business, grew 66%
over 2015. Most of these sales were to one customer, and we expect that this business will continue for future years. AMS has
achieved industry recognition for service and quality. We are anticipating additional business from three potential new customers in
2017 and 2018.
IKONICS Imaging also had a good year, with sales up 8% over 2015, driven primarily by a new customer, which is continuing to
increase its orders. We expect to introduce a new, patent-applied-for product to this market this year, which we believe will be an
important contributor to sales and profits.
DTX, our automotive-based product line, experienced a 15% decline in sales, mirroring the segment of the automotive market the
company serves. But based on firm orders in house, we expect that decline to reverse in the first half of 2017 and generate good
sales and profits.
Our traditional domestic screen print supply business was down 3%, reflecting the mature nature of this market. To counteract this,
we are making a major effort in the growing printed electronics sector where we are developing a unique product that allows the
printing of very fine circuits for touch pads, wearable electronics, antennas and other applications. This is a large market that could
bring us significant profits.
Our international business was down 8%, reflecting the strong dollar. We are looking for the printed electronics market described
above and the new product being developed for IKONICS Imaging to improve our export business.
For the year, overall sales were flat with 2015, with AMS and IKONICS Imaging countering the decline in International and DTX.
Unfortunately, we were hit with a large unforeseen increase in health care expenses in the fourth quarter of 2016. For the year,
our employee health care costs were $721,000 compared to $408,000 in 2015. This resulted in a loss of $0.03 per diluted share
for the year compared to 2015 earnings of $0.07 per diluted share. Without the $313,000 increase in healthcare costs, pre-tax
earnings on a non-GAAP basis would have increased by 8% over 2015. For a reconciliation to the comparable GAAP measure, see
the table below.
William C. Ulland
Chairman, President & CEO
March 24, 2017
Reconciliation of GAAP to Non-GAAP Pre-Tax Earnings
We report our financial results in accordance with U.S. generally accepted accounting principles (“GAAP”). We have provided non-
GAAP pre-tax earnings to assist investors in comparing earnings on a year-over-year basis and because management believes it
is a useful metric in evaluating ongoing performance of our company. Reconciliation to the comparable GAAP measure is below.
TWELVE MONTHS ENDED
12/31/16
12/31/15
GAAP pre-tax earnings (loss)
$
(69,061) $
225,007
Percentage decrease from prior fiscal year
(131%)
Add: Increase in health care costs
313,000
--
--
Non-GAAP pre-tax earnings
$
243,939 $
225,007
Percentage increase from prior fiscal year
8%
--
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
(Mark One)
Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Fiscal Year Ended December 31, 2016
or
For the Transition Period From to .
Commission file number 000-25727
IKONICS CORPORATION
(Exact name of registrant as specified in its charter)
Minnesota
(State or other jurisdiction of
incorporation or organization)
4832 Grand Avenue
Duluth, Minnesota
(Address of principal executive offices)
41-0730027
(I.R.S. employer
identification no.)
55807
(Zip code)
Securities registered under Section 12(b) of the Act:
Registrant’s telephone number, including area code: (218) 628-2217
Title of Each Class
Name of Each Exchange
On Which Registered
Common Stock, par value $.10 per share
Nasdaq Capital Market
Securities registered under Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No
Check whether the issuer is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act. Yes No
Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to
be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files.) Yes No
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained in this form, and will not be contained, to the
best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See
definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(do not check if smaller
reporting company)
Smaller reporting company
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
The aggregate market value of the voting stock held by non-affiliates of the registrant as of June 30, 2016 was $12,196,951 based on the most recent closing
price for the issuer’s Common Stock on such date as reported on the Nasdaq Capital Market. For purposes of determining this number, all officers and directors of the
issuer are considered to be affiliates of the issuer, as well as individual stockholders holding more than 10% of the issuer’s outstanding Common Stock. This number is
provided only for the purpose of this report on Form 10-K and does not represent an admission by either the issuer or any such person as to the status of such person.
State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practical date: Common Stock, $.10 par value —
2,018,753 issued and outstanding as of February 24, 2017.
This Annual Report on Form 10-K contains forward-looking statements within the meaning of the safe harbor
provisions of Section 21E of the Securities Exchange Act of 1934, as amended, relating to future events or the future
financial performance of the Company. In some cases, you can identify forward-looking statements by the following
words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,”
“potential,” “predict,” “project,” “should,” “will,” “would,” or the negative of these terms or other comparable
terminology, although not all forward-looking statements contain these words. Forward-looking statements are only
predictions or statements of intention subject to risks and uncertainties and actual events or results could differ
materially from those projected. Forward-looking statements are based on information available at the time the
statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results,
levels of activity, performance or achievements to be materially different from the information expressed or implied by
the forward-looking statements in Annual Report on Form 10-K. Factors that could cause actual results to differ include
the risks, uncertainties and other matters set forth below under the caption “Risk Factors” and the matters set forth
under the captions “Business” and “Management’s Discussion and Analysis of Financial Condition and Results of
Operations,” as well as those discussed elsewhere in this Annual Report on Form 10-K.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the Company’s definitive proxy statement for its 2017 Annual Meeting of Shareholders are
incorporated by reference in Part III.
2
Item 1. Business
General
PART I
IKONICS Corporation (“IKONICS” or the “Company”) was incorporated in Minnesota as Chroma-Glo, Inc. in
1952 and changed its name to The Chromaline Corporation in 1982. In December 2002, the Company changed its name
to IKONICS Corporation. The Company’s three traditional businesses, Domestic, IKONICS Imaging and Export, have
been the development, manufacture and selling of photosensitive liquids (“emulsions”) and films for the screen printing
and awards and recognition industries. These sales have been augmented with inkjet receptive films, ancillary chemicals
and related equipment to provide a full line of products and services to its customers. These products are sold worldwide
primarily through distributors. In 2006, the Company began a major effort to diversify and expand its business to
industrial markets. These efforts now include the Company’s Advanced Material Solutions (“AMS”) business unit which
uses the Company’s proprietary processes and photoresist film for the abrasive etching of composite materials, industrial
ceramics, silicon wafers, and glass wafers. The customer base for AMS is primarily the aerospace and electronics
industries. Based on its expertise in ultraviolet curable fluids and inkjet receptive substrates, the Company has also
developed a patented digital texturing technology (“DTX”) for putting patterns and textures into steel molds for the
plastic injection molding industry. The original equipment manufacturer (“OEM”) for the Company’s DTX technology
is primarily the automotive industry. The Company offers a suite of products to the mold making industry. Industrial
inkjet printers, which are integral to the DTX system, are manufactured by a third party and sold by IKONICS. The
Company’s business plan is to sell consumable fluids and transfer films. For most markets, these sales are direct to the
mold maker. The DTX technology is being expanded to prototyping where the Company’s technology offers a unique
combination of high definition, large format prints, and abrasion resistance.
Products
The Company has four primary technology platforms: ultraviolet (UV) chemistry, film coating and
construction, technical abrasive etching, and industrial inkjet printing. The Company’s traditional products and new
initiatives are based on these platforms and their combinations. The Company’s Chromaline branded products for the
screen printing industry and IKONICS Imaging products for the awards and recognition market are based on UV
chemistry and film coating and construction capabilities; the AMS offering is a combination of UV chemistry, film
coating and construction and technical abrasive etching capabilities; DTX is a combination of UV chemistry, film
coating and construction, and industrial inkjet printing. There is overlap and synergy in the market between the
Domestic, Ikonics Imaging, AMS and DTX product offerings, and the Company offers ancillary products, including
equipment to provide customers with a total solution. The Company considers this combination of core technologies
and product offerings to be unique.
Distribution and Customers
The Company currently has approximately 200 domestic and international distributors for its Chromaline
and ImageMate screen printing emulsions and films. The Company’s abrasive etching products are mainly sold directly
to end users in the awards and recognition market under the Ikonics Imaging brand. AMS products are sold either
directly to users or the Company offers AMS as a service. DTX includes the sales of consumable inks and films to
customers that have purchased specialized industrial inkjet printers from the Company’s strategic partner. DTX sales are
both direct to users and through distributors. The Company markets and sells its products through magazine advertising,
trade shows and the internet.
The Company has a diverse customer base both domestically and abroad, with international sales accounting
for 25.7% of total sales in 2016 and 27.9% of total sales in 2015, and does not depend on one or a few customers for a
material portion of its revenues. In 2016 and 2015, no one customer accounted for more than 10% of net sales.
Quality Control in Manufacturing
In March 1994, IKONICS became the first company in northern Minnesota to receive ISO 9001
certification. ISO 9000 is a worldwide standard issued by the International Organization for Standardization that
provides a framework for quality assurance. The Company has been recertified every three years beginning in
3
1997. IKONICS’ quality function goal is to train all employees properly in both their work and in the importance of
their work. Internal records of quality, including related graphs and tables, are reviewed regularly and discussions are
held among management and employees regarding how improvements might be realized. The Company has rigorous
materials selection procedures and also uses testing procedures to assure its products meet quality standards.
Research and Development and Intellectual Property
The Company incurred costs totaling 3.7% of sales, or $647,000, on research and development in 2016, and
3.8% of sales, or $660,000, in 2015. In its research program, IKONICS has developed ultraviolet light-sensitive
chemistries used in the manufacturing of screen print stencils, photoresists for abrasive etching and acid resist and
prototyping ink jet fluids and ink jet receptive films. The Company has a number of patents and patent applications on
these chemistries and applications. There can be no assurance that any patent granted to the Company will provide
adequate protection to the Company’s intellectual property. Within the Company, steps are taken to protect the
Company’s trade secrets, including physical security, confidentiality and non-competition agreements with employees,
non-disclosure agreements where applicable, and confidentiality agreements with vendors. Over the past few years, the
Company has directed a larger portion of it research and development resources towards industrial inkjettable fluids and
ink jet receptive substrates. The Company has also invested significant resources for personnel and equipment to
develop proprietary products and techniques for the etching of composite materials, industrial ceramics and electronic
wafers.
In addition to its patents, the Company has various trademarks including the “IKONICS,” “Chromaline,”
“IKONICS Imaging,” “Precision Abrasive Machining,” “SmartFlex,” “PhotoBrasive,” “AccuArt,” “Nichols,” “image
mate,” “Alpha FlexTrace,” “Alpha MicroCap,” and “DTX” trademarks.
Raw Materials
The primary raw materials used by IKONICS in its production are photopolymers, polyester films,
polyvinylacetates, polyvinylalcohols and water. The Company’s purchasing staff leads in the identification of both
domestic and foreign sources for raw materials and negotiates price and terms for all domestic and foreign
markets. IKONICS’ involvement in foreign markets has given it the opportunity to become a global buyer of raw
materials at lower overall cost. The Company has a number of suppliers for its operations. Some suppliers provide a
significant amount of key raw materials to the Company, but the Company believes alternative sources are available for
most materials. For those raw materials where an alternative source is not readily available, the Company has
contingency raw material replacement plans. To date, there have been no significant shortages of raw materials. The
Company believes it has good supplier relations.
Competition
The Company competes in its markets based on product development capability, quality, reliability,
availability, technical support and price. Though the screen printing market is much larger than the awards and
recognition market, IKONICS commands significantly more market share in the latter. IKONICS has two primary
domestic competitors in its screen printing film business. They are larger than IKONICS and possess greater resources
than the Company in many areas. The Company has numerous competitors in the market for screen print emulsions,
many of whom are larger than IKONICS and possess greater resources. The market for the Company’s abrasive etching
products in the awards and recognition market has one significant competitor. IKONICS considers itself to be the leader
in this market. There are significant competitors, using different technologies in the new markets being entered by the
Company. The primary competition for AMS is from other machining methods, most of which are well established. The
primary competition for DTX comes from old, well-established technologies based on wax and screen printing and new
competition from laser technologies.
Government Regulation
The Company is subject to a variety of federal, state and local industrial laws and regulations, including
those relating to the discharge of material into the environment and protection of the environment. The governmental
authorities primarily responsible for regulating the Company’s environmental compliance are the Environmental
Protection Agency, the Minnesota Pollution Control Agency and the Western Lake Superior Sanitary District. Failure to
comply with the laws promulgated by these authorities may result in monetary sanctions, liability for environmental
4
clean-up and other equitable remedies. To maintain compliance, the Company may make occasional changes in its
waste generation and disposal procedures.
These laws and regulations have not had a material effect upon the capital expenditures or competitive
position of the Company. The Company believes that it complies in all material respects with the various federal, state
and local regulations that apply to its current operations. Failure to comply with these regulations could have a negative
impact on the Company’s operations and capital expenditures and such negative impact could be significant.
The Company also is subject to regulations from foreign governments covering the importation of certain
chemicals. The Company believes that it complies in all material respects with these regulations that apply to its current
products. Failure to comply with these regulations could have a negative impact on the Company’s operations and
capital expenditures and such negative impact could be significant.
Employees
As of February 24, 2017, the Company had 80 full-time employees, 75 of whom are located at the
Company’s two facilities in Duluth, Minnesota and five of whom are outside technical sales representatives in various
locations in the United States. None of the Company’s employees are subject to a collective bargaining agreement and
the Company believes that its employee relations are good.
Item 1A. Risk Factors
The Company’s DTX and AMS initiatives involve new technologies that might not be executed successfully and might
not achieve market acceptance.
The Company’s DTX and AMS initiatives involve new technologies that might never achieve market
acceptance. During 2016 and 2015, the Company generated operating losses in its AMS segment while DTX realized
operating income for the first time in 2015 and was profitable again in 2016. The Company’s ability for generating
profits from these initiatives will depend on its products gaining market acceptance among customers, which cannot be
guaranteed. The degree of market acceptance of any new products the Company develops will depend on a number of
factors, including:
the Company’s ability to successfully develop its technologies and products to include the capabilities the
Company intends;
the Company’s ability to accurately assess the functions and features customers desire;
the perceived effectiveness and price of the Company’s products compared to alternative products and
technologies;
the development of new products and technologies by current competitors or new competitors that might enter
the Company’s markets; and
the strength of the Company’s marketing and distribution functions.
If new products that the Company develops do not have the capabilities the Company expects or fail to achieve
an adequate level of acceptance by customers for any reason, then the Company’s AMS and DTX business units could
fail to generate the revenues the Company expects and may not become profitable or sustain profitability.
If the Company’s new products and technologies do not achieve market acceptance, the Company will not realize a
return on its investments in its new business initiatives.
The Company has invested, and plans to continue to invest, significant resources in its research and
development efforts to develop technology for its AMS and DTX business units. The Company spent 3.7% of sales, or
$647,000, on research and development in 2016 and 3.8% of sales, or $660,000, in 2015. A substantial portion of these
investments was in the Company’s AMS and DTX initiatives. The Company plans to continue to invest significant
resources in research and development on these initiatives for the foreseeable future. The Company believes successful
5
execution of these initiatives is important for its ability to grow its revenues and profits. However, if the Company fails
to generate its projected revenues in these business units, the Company’s investments in these areas would not generate
the profits the Company expects and its results of operations, financial condition and prospects would be materially and
adversely affected.
Adverse changes to global economic conditions generally, and to the aerospace and automotive industries in
particular, may harm the Company’s business.
The prospects for economic growth in the United States and other countries remain uncertain and major
economies where the Company conducts business could continue or return to recessionary conditions. Economic
concerns and issues such as reduced access to capital for businesses may cause the Company’s customers to delay or
reduce purchases of the Company’s products. Given the continued uncertainty concerning the global economy, the
Company also faces risks that may arise from financial difficulties experienced by suppliers and customers, such as an
inability to collect receivables or the continued operation of suppliers.
The Company’s AMS segment focuses primarily on customers in the aerospace industry, and its DTX segment
focuses primarily on customers in the automotive industry. The aerospace and automotive industries have experienced
volatility in prior years in a manner similar to or greater than the global economy generally. If either or both these
industries experiences difficulties that reduce demand for their products generally, the Company’s results of operations,
financial condition and prospects would suffer.
The Company faces significant competition and expects to face increasing competition in many aspects of its
businesses, which could cause operating results to suffer.
The Company operates in highly competitive industries that experience rapid technological and market
developments, changes in customer needs, and frequent product introductions and improvements, particularly with
respect to the AMS and DTX businesses. If the Company is unable to anticipate and respond to these developments, its
products or technologies could become uncompetitive or obsolete. Most of the Company’s competitors in the AMS and
DTX fields are larger and better capitalized than the Company with longer operating histories. These advantages could
allow the Company’s competitors to invest more resources in research and development and sales and marketing than
the Company, which could make the competitive products more attractive or better known to consumers than the
Company’s products. In addition, because there is potential for rapid technological change in fields in which the
Company operates, the Company could face competition from new sources in the future that customers find more
attractive.
The Company also could face increased competition in its traditional Domestic and IKONICS Imaging units.
Capital costs for machinery necessary to operate in these industries have decreased in recent years, increasing the
possibility that the Company will face new competitors. An increase in the amount of competition the Company faces,
or a loss of competitiveness in any of the Company’s business units for any reason, could adversely affect its revenues
and gross margins.
The Company’s failure to comply with environmental laws and regulations could harm its business and results of
operations.
The manufacturing of the Company’s products requires the use of hazardous materials that are subject to a
broad array of environmental laws and regulations. The Company’s failure to comply with these laws or regulations
could result in:
regulatory penalties, fines and legal liabilities;
suspension of production;
alteration of manufacturing processes; and
restrictions on the Company’s operations or sales.
6
The Company’s failure to manage the use, transportation, emissions, discharge, storage, recycling or disposal of
hazardous materials could lead to increased costs or future liabilities. Environmental laws and regulations also could
require the Company to acquire pollution abatement or remediation equipment, modify product designs or incur other
expenses.
Third parties may claim the Company infringes their intellectual property rights, which could harm the Company’s
business.
The Company may face claims that it infringes other parties’ intellectual rights. Regardless of a claim’s merit,
claims that the Company’s products or processes infringe the intellectual property rights of others could cause the
Company to incur large costs to respond to, defend, and resolve the claims, and they may divert the efforts and attention
of management and technical personnel. As a result of any intellectual property rights infringement claims, the
Company could be required to:
pay infringement claims;
stop manufacturing, using, or selling products or technology subject to infringement claims;
develop other products or technology not subject to infringement claims, which could be time-consuming,
costly or impossible; or
license technology from the party claiming infringement, which license may not be available on commercially
reasonable terms, if at all.
These actions could harm the Company’s competitive position, result in additional expenses, or require the
Company to impair its assets. If the Company alters or stops production of affected items, its ability to generate revenue
could be harmed.
The Company may be unable to enforce or protect its intellectual property rights, which may harm its ability to
compete and may harm its business.
The Company’s ability to enforce its patents, trademarks and other intellectual property rights is subject to
general litigation risks, as well as uncertainty as to the enforceability of the Company’s intellectual property rights in
various countries. If the Company seeks to enforce its rights, it could become subject to claims that its intellectual
property rights are invalid, not enforceable, or licensed to the opposing party. The Company’s assertion of intellectual
property rights also could result in the other party seeking to assert claims against the Company, which could harm the
Company’s business. The Company’s inability to enforce its intellectual property rights for any reason could harm its
competitive position and business.
If the Company is unable to protect the confidentiality of its proprietary information and know-how, the value of its
technology could be adversely affected.
In addition to patented technology, the Company relies on unpatented proprietary technology, trade secrets,
processes and know-how. The Company generally seeks to protect this information by confidentiality agreements with
employees, consultants, advisors and third parties. These agreements may be breached, and the Company may not have
adequate remedies for any such breach. In addition, the Company’s trade secrets may otherwise become known or be
independently developed by competitors. To the extent that the Company’s employees, consultants or contractors use
intellectual property owned by others in their work for the Company, disputes may arise as to the rights in related or
resulting know-how and inventions.
The Company operates a global business that exposes it to additional risks.
The Company operates throughout the world, including in the United States, Europe and China. These
international operations create a variety of risks and uncertainties, including:
rapid changes in government, economic and political policies and conditions, political or civil unrest or
instability, terrorism or epidemics;
7
fluctuations in foreign currency exchange rates;
compliance with and changes in foreign laws and regulations, as well as U.S. laws affecting the activities of
U.S. companies abroad, including the Foreign Corrupt Practices Act of 1977, as amended (the “FCPA”);
different, complex and changing laws governing intellectual property rights, sometimes affording companies
lesser protection in certain areas;
longer accounts receivable payment cycles and difficulties in collecting accounts receivable;
protectionist laws and business practices that favor local producers; and
potentially adverse tax consequences, including the complexities of foreign value added tax systems and
restrictions on the repatriation of earnings.
The occurrence of any one of these risks could negatively affect the Company’s international business and,
consequently, its results of operations generally.
The Company faces risks related to sales through distributors and other third parties.
During 2016, a significant portion of the Company’s sales, including nearly all sales of its Domestic products
and nearly all of its International sales, were conducted through third parties. Using third parties for distribution exposes
the Company to many risks, including competitive pressure, concentration, credit risk and compliance risks. Distributors
may sell products that compete with the Company’s products, and the loss of a distributor could reduce the Company’s
revenue. Distributors may face financial difficulties, including bankruptcy, which could harm the Company’s collection
of accounts receivable and financial results. Violations of the FCPA or similar laws by distributors or other third-party
intermediaries could have a material impact on the Company’s business. Failing to manage risks related to the
Company’s use of distributors may reduce sales, increase expenses, and weaken its competitive position.
Increases in prices and declines in the availability of raw materials could negatively impact the Company’s financial
results.
Certain raw materials needed to manufacture products are obtained from a limited number of suppliers and
many of the raw materials are petroleum-based. Under normal market conditions, these raw materials are generally
available on the open market from a variety of producers. While alternate supplies of most key raw materials are
available, supplier production outages may lead to strained supply-demand situations for certain raw materials. The
substitution of key raw materials could require the Company to identify new supply sources, or reformulate and retest
products or processes. From time to time, the prices and availability of these raw materials may fluctuate, which could
impair the Company’s ability to procure necessary materials, or increase the cost of manufacturing products. If the
prices of raw materials increase in a short period of time, the Company may be unable to pass these increases on to its
customers in a timely manner or at all, which could reduce its gross margins. Like most companies in the Company’s
industries, the Company does not have long-term supply contracts for most of its key raw materials, which exacerbates
the foregoing risks to the Company.
If any of the Company’s present single or limited source suppliers become unavailable or inadequate, its customer
relationships, results of operations and financial condition may be adversely affected.
The Company acquires certain of its materials that are critical to its operations from a limited number of third
parties. Should any of the Company’s current single or limited source suppliers become unavailable or inadequate, or
impose terms unacceptable to the Company such as increased pricing terms, the Company could be required to spend a
significant amount of time and expense to develop alternate sources of supply, and may not be successful in doing so on
acceptable terms or at all. If the Company is unable to find a suitable supplier for a particular material, it could be
required to modify its existing business processes or offerings to accommodate the situation. As a result, the loss of a
single or limited source supplier could adversely affect the Company’s relationship with its customers and its results of
operations and financial condition.
8
The Company depends on one manufacturer to make and sell DTX printers. If the manufacturer ceased to make or
sell DTX printers, or failed to meet quality standards, the Company’s financial results and prospects would be
adversely affected.
The Company relies on one company to manufacture and sell DTX printers. If the manufacturer ceased to
produce or devote resources to selling DTX printers, due to a change in company strategy, to focus on alternative
initiatives, or for any other reason, the Company would need to find an alternative manufacturer and seller of DTX
printers. Finding an alternative manufacturer and seller of DTX printers could result in additional costs and delays in
growing the Company’s DTX business unit, which would adversely affect the Company’s financial results and
prospects.
In addition, if these manufacturers failed to produce DTX printers that satisfy the Company’s quality standards,
the Company’s reputation with end users could be harmed and the Company could be forced to find a new manufacturer.
Either of these results also would harm the Company’s business and prospects.
The inability to attract and retain qualified personnel could adversely impact the Company’s business.
Sustaining and growing the Company’s business depends on the recruitment, development and retention of
qualified employees, including management and research and development personnel. The inability to recruit and retain
key personnel or the unexpected loss of key personnel may adversely affect the Company’s operations.
An active trading market for the Company’s shares of common stock may not develop.
The Company’s common stock has been listed for trading on the Nasdaq Capital Market since 1999 and
persistently has experienced limited trading volume. There can be no assurance that an active public market for the
Company’s shares will develop or be sustained. The lack of an active trading market could adversely affect the price
and liquidity of the Company’s common stock.
The Company’s directors and officers own a large percentage of the Company’s common stock, which may allow
them to collectively exert significant influence over substantially all matters requiring shareholder approval.
As of December 31, 2016, the Company’s directors and officers collectively beneficially owned approximately
24.3% of its common stock outstanding as of that date. As a result, the Company’s directors and officers could exert
significant influence over all matters requiring a shareholder vote, including the election of directors, amendments to the
Company’s articles of incorporation, and extraordinary transactions such as mergers or going private transactions. These
ownership positions may have the effect of delaying, deterring or preventing a change in control or a change in the
composition of the Company’s board of directors. In addition, substantial sales of shares beneficially owned by our
directors or officers could be viewed negatively by third parties and have a negative impact on the Company’s stock
price.
The price of the Company’s common stock may fluctuate significantly.
The price of the Company’s common stock has, and could continue to, fluctuate substantially in a short period
of time. The price of the Company’s common stock could vary for many reasons, including the following:
future announcements concerning the Company or its competitors;
introduction of new products by the Company or its competitors, or the failure of the Company’s new products
to meet expectations;
the commencement of, or developments to, litigation involving the Company;
quarterly variations in operating results, which the Company has experienced in the past and expects to
experience in the future;
business acquisitions or divestitures; or
9
changes to the global economy in general, and the aerospace and automotive markets in particular.
In addition, stock markets in general have experienced price and volume fluctuations in recent years,
fluctuations that sometimes have been unrelated to the operating performance of the affected companies. These broad
market fluctuations may adversely affect the market price of the Company’s common stock. The market price of the
Company’s common stock could decline below its current price and the market price of the Company’s shares may
fluctuate significantly in the future. These fluctuations may be unrelated to the Company’s performance.
The Company’s operating results and financial condition may fluctuate on a quarterly and annual basis.
The Company’s operating results and financial condition may fluctuate from quarter to quarter and year to year,
and could vary due to a number of factors, some of which are outside of the Company’s control. In addition, the
Company’s actual or projected operating results may fail to match its past performance. The Company’s operating
results and financial condition may fluctuate due to a number of factors, including those listed below and those identified
throughout this “Risk Factors” section:
the failure of the Company’s new products to meet expectations;
changes to the costs of raw materials, especially petroleum-based materials;
the entry of new competitors into the Company’s markets whether by established companies or by new
companies;
the geographic distribution of the Company’s sales;
changes in customer preferences or needs;
changes in the amount that the Company invests to develop or acquire new technologies;
delays between the Company’s expenditures to develop new technologies and products and the generation of
sales related thereto;
changes in the Company’s pricing policies or those of its competitors;
changes in accounting rules and tax and other laws; and
general economic and industry conditions that affect customer demand and product development trends.
Due to all of the foregoing factors and the other risks discussed in this “Risk Factors” section, you should not
rely on quarter-to-quarter or year-to-year comparisons of the Company’s operating results as an indicator of future
performance.
Item 1B. Unresolved Staff Comments
None
Item 2. Property
The Company primarily conducts its operations in Duluth, Minnesota. The administrative, sales, research and
development, quality and most of the manufacturing activities are housed in a 60,000 square-foot, four-story building,
including a basement level. The building is approximately seventy years old and has been maintained in good
condition. The Company also utilizes a 5,625 square-foot warehouse adjacent to the existing plant building that was
constructed in 1997. These facilities are owned by the Company with no existing liens or leases. The Company also
owns an approximately 11-acre property with a 35,000 square-foot manufacturing and warehouse facility. In addition to
warehousing and shipping functions, the facility accommodates some manufacturing activities. In 2016, the Company
completed construction of a 27,300 square-foot expansion to its 35,000 square-foot warehousing and manufacturing
10
facility. The expansion accommodates the Company’s AMS business. The entire facility on the 11-acre property is
collateral on the Company’s $3.2 million loan.
Item 3. Legal Proceedings
None.
Item 4. Mine Safety Disclosures
Not applicable.
11
PART II
Item 5. Market for Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
The Company’s Common Stock is traded on the Nasdaq Capital Market under the symbol IKNX. The
following table sets forth, for the fiscal quarters indicated, the high and low sales prices for the Company’s Common
Stock as reported on the Nasdaq Capital Market for the periods indicated.
Fiscal Year Ended December 31, 2016:
First Quarter
Second Quarter
Third Quarter
Fourth Quarter
Fiscal Year Ended December 31, 2015:
First Quarter
Second Quarter
Third Quarter
Fourth Quarter
High
Low
$ 12.33 $ 10.29
10.20
10.25
10.47
11.95
13.95
12.00
$ 20.43 $ 14.25
13.75
11.00
9.76
16.00
15.62
12.00
As of February 24, 2017, the Company had 559 shareholders. The Company has not declared cash dividends in
the past two years and does not currently have plans to pay any cash dividends in the future. Any future declaration and
payment of dividends is within the sole discretion of the Company’s board of directors.
Item 6. Selected Financial Data
Not applicable
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following management discussion and analysis focuses on those factors that had a material effect on the
Company’s financial results of operations and financial condition during 2016 and 2015 and should be read in
conjunction with the Company’s audited financial statements and notes thereto for the years ended December 31, 2016
and 2015, included herein.
Critical Accounting Policies and Estimates
The Company prepares its financial statements in conformity with accounting principles generally accepted in
the United States of America. Therefore, the Company is required to make certain estimates, judgments and
assumptions that the Company believes are reasonable based upon the information available. These estimates and
assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported
amounts of revenues and expenses during the periods presented. The accounting policies and estimates which IKONICS
believes are the most critical to aid in fully understanding and evaluating its reported financial results include the
following:
Revenue Recognition. The Company recognizes revenue on sales of products when title passes, which can
occur at the time of shipment, or when the goods arrive at the customer location depending on the agreement with the
customer. The Company sells its products to both distributors and end-users. Sales to distributors and end-users are
recorded based upon the criteria governed by the sales, delivery, and payment terms stated on the invoices from the
Company to the purchaser. In addition to transfer of title / risk of loss, all revenue is recorded in accordance with the
criteria outlined within SAB 104 and FASB ASC 605, Revenue Recognition:
(a)
persuasive evidence of an arrangement (principally in the form of customer sales orders and
the Company’s sales invoices);
12
(b)
(c)
delivery and performance (evidenced by proof of delivery, e.g. the shipment of film and
substrates with bill of lading used for proof of delivery for FOB shipping point terms, and the
carrier booking confirmation report used for FOB destination terms). Once the finished
product is shipped and physically delivered under the terms of the invoice and sales order, the
Company has no additional performance or service obligations to complete;
a fixed and determinable sales price (the Company’s pricing is established and is not based
on variable terms, as evidenced in either the Company’s invoices or the limited number of
distribution agreements; the Company rarely grants extended payment terms and has no
history of concessions); and
(d)
a reasonable likelihood of payment (the Company’s terms are standard, and the Company
does not have a substantial history of customer defaults or non-payment).
Sales are reported on a net basis by deducting credits, estimated normal returns and discounts. The Company’s
return policy does not vary by geography. The customer has no rotation or price protection rights and the Company is
not under a warranty obligation. Freight billed to customers is included in sales. Shipping costs are included in cost of
goods sold.
Trade Receivables. The Company performs ongoing credit evaluations of its customers and adjusts credit
limits based upon payment history and the customer’s current credit worthiness, as determined by review of the current
credit information. The Company continuously monitors collections and payments from its customers and maintains a
provision for estimated credit losses based upon historical experience and any specific customer collection issues that
have been identified. While such credit losses have historically been within expectations and the provisions established,
the Company cannot guarantee that it will continue to experience the same collection history that has occurred in the
past. The general payment terms are net 30-45 days for domestic customers and net 30-90 days for foreign customers.
A small percentage of the trade receivables balance is denominated in a foreign currency with no concentration in any
given country. At the end of each reporting period, the Company analyzes the receivable balance for customers paying
in a foreign currency. These balances are adjusted to each quarter or year-end spot rate. The Company also maintains a
provision based upon historical experience and any specifically identified issues for any customer related returns,
refunds or credits.
Inventories. Inventories are valued at the lower of cost or market value using the last in, first out (LIFO)
method. The Company monitors its inventory for obsolescence and records reductions from cost when required.
Income Taxes. Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for
deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are
recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts
of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the
opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
The Company follows the accounting standard on accounting for uncertainty in income taxes, which addresses the
determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the
financial statements. Under this guidance, the Company may recognize the tax benefit from an uncertain tax position
only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the
technical merits of the position. The tax benefits recognized in the financial statements from such a position are
measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate
settlement. The guidance on accounting for uncertainty in income taxes also addresses derecognition, classification,
interest and penalties on income taxes, and accounting in interim periods.
Results of Operations
Year Ended December 31, 2016 Compared to Year Ended December 31, 2015
Sales. The Company’s net sales in 2016 of $17.6 million were consistent with 2015 sales. Sales in 2016 were
favorably impacted by an AMS sales increase due to growth from its composite machining. AMS sales in 2016
13
increased by 65.8%, from $628,000 in 2015 to $1.0 million in 2016. IKONICS Imaging sales also increased by 7.6% for
the period from $4.0 million in 2015 to $4.3 million in 2016, mainly related to the acquisition of a new customer.
Partially offsetting these sales increases was a drop in Export sales. Compared to 2015, Export sales in 2016 decreased
$388,000, or 7.9%, as the strong U.S. dollar continues to dampen sales. Compared to the prior year, 2016 sales were
down across all regions with the exception of Europe. Domestic also realized lower sales for 2016 with a $247,000, or
3.2%, sales decrease versus 2015 as sales were down across all product groups. DTX sales decreased 15.0% from
$476,000 in 2015 to $405,000 in 2016 primarily due to a decrease in demand for film from its largest customer during
the first half of the year.
Gross Profit. Gross profit was $6.2 million, or 35.5% of sales, in 2016 compared to $6.1 million, or 35.0% of
sales in 2015. IKONICS Imaging gross margin for 2016 was favorably impacted by higher sales volumes, and an
increase in higher margin film sales as gross margin percentage increased from 53.1% in 2015 to 55.2% in 2016.
Despite lower volumes, the DTX gross margin improved to 59.9% in 2016 from 46.5% in 2015 due to lower personnel
and depreciation expenses. Higher AMS sales volumes resulted in the AMS gross margin improving from a negative
81.2% in 2015 to a negative 49.6% in 2016. Lower raw material costs improved the Domestic gross margin percentage
from 42.1% in 2015 to 42.9% in 2016, while lower volumes resulted in the Export gross margin decreasing from 23.1%
in 2015 to 22.3% in 2016.
Selling, General and Administrative Expenses. Selling, general and administrative expenses were $5.6 million,
or 31.9% of sales, in 2016 compared to $5.3 million, or 30.0% of sales, in 2015. The increase in selling, general and
administrative expenses reflects higher health insurance expenses in 2016. IKONICS utilizes a self-funded medical
insurance plan and can experience fluctuations in medical insurance costs. The Company mitigates part of the risk under
this self-funded plan by purchasing both specific and aggregate stop-loss insurance coverage. The increase in selling,
general and administrative expenses also reflects additional promotional and trade show expenses for both Domestic and
AMS markets in addition to higher Exports sales expenses related to Asia.
Research and Development Expenses. Research and development expenses in 2016 were $647,000, or 3.7% of
sales, versus $660,000, or 3.8% of sales in 2015. In 2015 the Company incurred a $46,000 expense related to the
abandonment of patent applications. The Company records patent application costs as an asset and amortizes those
costs upon successful completion of the application process or expenses those costs when an application is abandoned.
There was no patent abandonment in 2016.
Income Taxes. During 2016, the Company realized an income tax benefit of $4,000, or an effective rate of
5.8%, compared to income tax expense of $90,000, or an effective rate of 40.0%, for the same period in 2015. The
change to income tax benefit in 2016 from income tax expense from 2015 is primarily due to the pre-tax book loss
generated in 2016 compared to the pre-tax book income generated in 2015. The decrease in the effective tax rate for
2016 from 2015 is primarily due to the pre-tax book loss generated in 2016 and unfavorable non-deductible items. In
2016, the unfavorable non-deductible items decreased the effective tax rate due to pre-tax book losses, while they
increased the effective tax rate in 2015 due to pre-tax book income. The effective tax rates in 2016 and 2015 primarily
differ from the expected tax rate due to the benefits of the domestic manufacturing deduction in 2015, credits for
research and development, and other non-deductible items.
Liquidity and Capital Resources
Outside of the building expansion, for which $3.4 million in financing was obtained during 2016, the Company
has financed its operations principally with funds generated from operations. These funds have been sufficient to cover
the Company’s normal operating expenditures, annual capital requirements, and research and development expenditures.
Cash and cash equivalents were $1.0 million and $2.2 million at December 31, 2016 and 2015, respectively. In
addition to its cash, the Company also held $3.2 million of short-term investments as of December 31, 2016. The
Company held no short-term investments as of December 31, 2015. The Company generated $917,000 in cash from
operating activities during 2016, compared to generating $1.5 million of cash from operating activities in 2015. Cash
provided by operating activities is primarily the result of the net income (loss) adjusted for non-cash depreciation and
amortization, deferred taxes, and certain changes in working capital components discussed in the following paragraph.
During 2016, inventories decreased by $134,000 related to a decrease in raw material inventories compared to
2015. The timing of collections resulted in a $171,000 trade receivables increase in 2016 versus 2015. Accounts
14
payable increased from 2015 to 2016 by $310,000 due to the timing of payments to and purchases from vendors.
Prepaid expenses and other assets increased $276,000 from 2015 to 2016. The increase is mainly related to prepayments
on equipment being manufactured with the expectation that it will be completed and sold in 2017. Compared to 2015,
accrued expenses increased $74,000 reflecting the timing of compensation payments and an increase in the accrual for
medical expenses. Income taxes receivables decreased $37,000 due to the timing of estimated 2016 tax payments
compared to the calculated 2016 tax liability.
During 2015, inventories decreased by $511,000. The lower inventory balance reflects efforts to tighten
inventory levels on hand along with the timing of raw material purchases. Trade receivables increased $69,000 related
to increased fourth quarter sales. Accounts payable increased $49,000 due to the timing of payments to and purchases
from vendors while accrued liabilities increased $8,000. Income taxes receivable decreased $61,000 due to the timing of
estimated 2015 tax payments compared to the calculated 2015 tax liability.
During 2016, cash used in investing activities was $5.3 million. The Company purchased 19 certificates of
deposits totaling $4.4 million. Five certificates of deposits totaling $1.1 million matured during 2016. The Company’s
cash purchases of property and equipment were $2.1 million in 2016. Total building expansion expenditures for 2016
were $1,393,000. Expenditures on the new ERP system in 2016 were $281,000. The remaining capital expenditures
were mainly for upgrades to improve AMS production and process capabilities. Also during 2016, the Company
incurred $27,000 in patent application costs that the Company records as an asset and amortizes upon successful
completion of the application process. In addition, the Company sold equipment for $21,000.
During 2015, cash used by investing activities was $1.2 million. Fifteen certificates of deposits totaling $2.4
million matured during 2015. The Company purchased three certificates of deposits totaling $650,000 during the same
period. The Company’s purchases of property and equipment were $3.2 million in 2015. Total building expansion
expenditures were $2.3 million, but $315,000 of the expenditures were included as part of construction payable and not
as cash used in investing activities. Similarly, expenditures on the new ERP system in 2015 were $208,000 of which
$18,000 was included as part of construction payable and not as cash used in investing activities. The remaining capital
expenditures were mainly for upgrades to improve AMS production and process capabilities and costs associated with
mandatory elevator upgrades. Also during 2015, the Company incurred $53,000 in patent application costs that the
Company records as an asset and amortizes upon successful completion of the application process.
During 2016, the Company received $3.2 million from financing activities. The Company secured a loan of
$3.4 million to finance the expansion of its AMS facility. Related to securing the loan, the Company paid $139,000 in
debt issuance costs and made principal payments of $79,000. During 2016, the Company received $4,000 from the
issuance of 500 shares of common stock pursuant to the exercise of stock options. There were no financing activities
during 2015.
On April 1, 2016, the Company entered into a financing agreement to borrow $3.4 million. The proceeds from
the loan were used to finance the construction of a 27,300-square foot building, as well as related equipment for use in
the Company’s manufacture of sound deadening technology used in the aerospace industry and products consisting of
etched composites, ceramics, glass and silicon wafers, to be located in Duluth, Minnesota. The Loan requires monthly
payments of approximately $18,000, including interest. The Loan bears interest at a rate of 2.14% per year, payable
monthly, and matures on April 1, 2041. The Loan is subject to mandatory purchase provisions, under which any owners
of the Bonds (the “Owners”) may tender the Bonds to the Issuer on April 1, 2021, which would result in the Company
repaying the outstanding loan principal and any outstanding accrued and unpaid interest to the Issuer at that time. If in
the event the Bonds are not repurchased on April 1, 2021, the Bonds shall be subject to the interest rate and redemption
provisions set forth in the associated covenant agreement. Including debt costs of approximately $139,000, the Loan’s
effective annual interest rate is 2.77%. The Company is subject to certain customary covenants set forth in the
associated covenant agreement, including a requirement that the Company maintain a debt service coverage ratio as of
the end of each calendar quarter of not less than 1.25 to 1.00 on a rolling four-quarter basis.
A bank line of credit exists providing for borrowings of up to $2.1 million and expires on May 31, 2017. The
Company expects to obtain a similar line of credit when the current line of credit expires. The line of credit is
collateralized by the Company’s assets and bears interest at 1.8 percentage points over the 30-day LIBOR rate. The
Company did not utilize this line of credit during 2016 or 2015 and there were no borrowings outstanding as of
December 31, 2016 and December 31, 2015. There are no financial covenants related to the line of credit.
15
The Company believes that current financial resources, its line of credit, cash generated from operations and
secured through debt financing, and short term investments, along with the Company’s capacity for additional debt
and/or equity financing will be sufficient to fund current and anticipated business operations. The Company also
believes that it is unlikely that a decrease in demand for the Company’s products would impair the Company’s ability to
fund operations given its excess cash and available line of credit.
Capital Expenditures
In 2016, the Company incurred $1.7 million of capital expenditures. A majority of the expenditures were
related to the AMS building expansion. The remaining capital expenditures were for upgrades to improve AMS
production and process capabilities, as well as for a new ERP system.
In 2015, the Company incurred $3.2 million of capital expenditures, of which $2.3 million was related to the
building expansion, including the $315,000 in construction accounts payable. The remaining capital expenditures were
mainly for upgrades to improve production and process capabilities for both AMS and the Company’s traditional
businesses, a new ERP system which was completed in 2016, data center equipment, and costs associated with
mandatory elevator upgrades, including $18,000 in construction accounts payable.
The Company expects capital expenditures in 2017 of approximately $600,000. The planned expenditures
primarily will be for manufacturing equipment to improve processes and capabilities for AMS, other manufacturing
equipment upgrades and vehicles for sales personnel. These commitments are expected to be funded with cash
generated from operating activities.
International Activity
The Company markets its products in numerous countries in various regions of the world, including North
America, Europe, Latin America, and Asia. The Company’s 2016 foreign sales of $4.5 million were approximately
25.7% of total sales, compared to the 2015 foreign sales of $4.9 million, which were 27.9% of total sales. The Company
experienced a decrease in foreign sales across all geographic regions in 2016 except Europe as the strong U.S. dollar
continues to negatively impact foreign sales.
The Company’s foreign transactions are primarily negotiated, invoiced and paid in U.S. dollars, though a
portion is transacted in Euros. IKONICS has not implemented an economic hedging strategy to reduce the risk of
foreign currency translation exposures, which management does not believe to be significant based on the scope and
geographic diversity of the Company’s foreign operations. Furthermore, the impact of foreign exchange on the
Company’s balance sheet and operating results was not material in either 2016 or 2015.
Future Outlook
IKONICS has spent an average of approximately 4.0% of annual sales in research and development and has
made capital expenditures related to new products and programs. The Company plans to maintain its efforts in these
areas to expedite internal product development as well as to form technological alliances with outside entities to
commercialize new product opportunities.
The Company continues to make progress on its AMS business initiative, which is now experiencing strong
growth. The Company has two long-term agreements in place for its technology with major aerospace companies and is
negotiating a third. In anticipation of this growing business, the Company increased its AMS capacity with a 27,300
square foot expansion at its Morgan Park site.
The Company is also continuing to pursue DTX related business initiatives. In addition to making efforts
towards growing the inkjet technology business, the Company offers a range of products for creating texture surfaces
and has introduced a fluid for use in prototyping. The Company is currently working on production improvements to
enhance its customer offerings. The Company has been awarded European, Japanese and United States patents on its
DTX technologies. The Company has also modified its DTX technology to enter the market for prototyping.
Both the Domestic and IKONICS Imaging units remain profitable in mature markets. Although these business
units require aggressive strategies to grow market share, both are developing new products and business relationships
16
that we believe will contribute to growth. In addition to its traditional emphasis on domestic markets, the Company will
continue efforts to grow its business internationally by attempting to develop new markets and expanding market share
where it has already established a presence. However, the strong U.S. dollar has made this challenging.
Other future activities undertaken to expand the Company’s business may include acquisitions, building
improvements, equipment additions, new product development and marketing opportunities.
Off-Balance Sheet Arrangements
The Company has no off-balance sheet arrangements.
Recent Accounting Pronouncements
In 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-15, Presentation of Financial
Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a
Going Concern, intended to define management’s responsibility to evaluate whether there is substantial doubt about an
organization’s ability to continue as a going concern and to provide related footnote disclosures. ASU 2014-15 is
effective for the Company in the year ended December 31, 2016, and interim periods beginning March 31, 2017, with
early application permitted. The adoption of ASU 2014-15 did not have a material impact to the financial statements
when implemented.
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers. ASU
2014-09 supersedes the revenue recognition requirements in Revenue Recognition (Topic 605), and requires entities to
recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that
reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. In August
2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, which
defers the adoption of ASU 2014-09 to annual reporting periods beginning after December 15, 2017, including interim
reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods
beginning after December 15, 2016, including interim reporting periods within that reporting period. The standard
permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or
retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application
(the cumulative catch-up transition method). The standard also requires expanded disclosures relating to the nature,
amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. Additionally,
qualitative and quantitative disclosures are required about customer contracts, significant judgments and changes in
judgments, and assets recognized from the costs to obtain or fulfill a contract. While the Company is still in the process
of evaluating the effect of adoption on its financial statements and is currently assessing its contracts with customers, the
Company anticipates that it will expand its financial statement disclosures in order to comply with the new standard. The
Company has established a timeline and process to evaluate the impact, transition and disclosure requirements of the
ASU and believes the timeline is sufficient to allow the Company to effectively implement the new standard. The
Company has not yet concluded on a transition method upon adoption, but plans to select a transition method by the
fourth quarter of 2017.
In 2015, the FASB issued ASU No. 2015-17, Income Taxes (Topic 740) Balance Sheet Classification of
Deferred Taxes, now requiring that deferred tax assets and liabilities be classified as noncurrent in a classified balance
sheet. The amendment takes effect for public entities for fiscal years beginning after December 15, 2016, with early
adoption available. The Company adopted this guidance for the quarter ended March 31, 2016 with retrospective
application and reclassified comparative periods for consistency. For 2015, a long-term deferred tax liability of
$580,000 has been netted with the current deferred tax asset of $195,000 for a net long-term deferred tax liability of
$385,000.
In April 2015, the FASB issued ASU No. 2015-03, Interest-Imputation of Interest: Simplifying the Presentation
of Debt Issuance Costs. ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be
presented in the balance sheet as a direct deduction from the carrying amount of that debt liability rather than as an asset.
The standard is effective for fiscal periods beginning after December 15, 2015, and interim periods therein and early
application is permitted. Companies are required to adopt the standard retrospectively. The standard will result in all
deferred financing costs, excluding transaction costs incurred in connection with securing revolving credit facilities,
17
being deducted from long-term debt obligations in our balance sheets. The Company adopted the provisions of ASU
No. 2015-03 during 2016. The effect of the adoption did not result in a change to equity or net income.
During February 2016, the FASB issued ASU No. 2016-02, Leases. ASU No. 2016-02 was issued to increase
transparency and comparability among organizations by recognizing all lease transactions (with terms in excess of 12
months) on the balance sheet as a lease liability and a right-of-use asset (as defined). ASU No. 2016-02 is effective for
fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, with earlier
application permitted. Upon adoption, the lessee will apply the new standard retrospectively to all periods presented or
retrospectively using a cumulative effect adjustment in the year of adoption. The Company does not expect the adoption
of ASU No. 2016-02 to have a material impact on its financial statements.
In March 2016, the FASB issued ASU No. 2016-09, Compensation—Stock Compensation (Topic 718). This
standard makes several modifications to Topic 718 related to the accounting for forfeitures, employer tax withholding on
share-based compensation and the financial statement presentation of excess tax benefits or deficiencies. ASU 2016-09
also clarifies the statement of cash flows presentation for certain components of share-based awards. The standard is
effective for interim and annual reporting periods beginning after December 15, 2016, although early adoption is
permitted. The Company is currently assessing the effect that ASU No. 2016-09 will have on its financial statements.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Not applicable
18
Item 8. Financial Statements
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders
IKONICS Corporation
We have audited the accompanying balance sheets of IKONICS Corporation as of December 31, 2016 and 2015, and the
related statements of operations, stockholders’ equity, and cash flows for the years then ended. These financial
statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these
financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United
States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to
perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control
over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for
the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.
Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the
amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates
made by management, as well as evaluating the overall financial statement presentation. We believe that our audits
provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of
IKONICS Corporation as of December 31, 2016 and 2015, and the results of its operations and its cash flows for the
years then ended, in conformity with U.S. generally accepted accounting principles.
/s/ RSM US LLP
Duluth, Minnesota
March 3, 2017
19
IKONICS CORPORATION
BALANCE SHEETS
DECEMBER 31, 2016 AND 2015
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Short-term investments
Trade receivables, less allowance of $54,000 in 2016 and $122,000 in 2015
Inventories
Prepaid expenses and other assets
Income taxes receivable
Total current assets
PROPERTY, PLANT, AND EQUIPMENT, at cost:
Land and building
Machinery and equipment
Office equipment
Vehicles
Construction in progress
Less accumulated depreciation
INTANGIBLE ASSETS, less accumulated amortization of $149,072 in 2016 and
$123,957 in 2015
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Current portion of long-term debt, net
Accounts payable
Trade
Construction
Accrued compensation
Other accrued liabilities
Total current liabilities
LONG-TERM LIABILITIES
Long-term debt, less current portion, net
Deferred income taxes
Total long-term liabilities
Total liabilities
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ EQUITY
Preferred stock, par value $.10 per share; authorized 250,000 shares; none issued
Common stock, par value $.10 per share; authorized 4,750,000 shares; issued and
outstanding 2,018,753 shares in 2016 and 2,018,253 in 2015
Additional paid-in-capital
Retained earnings
Total stockholders’ equity
See notes to financial statements.
2016
2015
$ 1,048,713 $ 2,248,466
—
2,165,194
2,119,805
85,648
102,778
6,721,891
3,246,000
2,336,501
1,986,172
361,905
66,181
9,045,472
9,189,743
4,884,814
1,566,856
272,144
—
15,913,557
(7,001,162)
8,912,395
6,391,555
4,275,910
933,596
272,141
2,491,432
14,364,634
(6,407,304)
7,957,330
338,127
336,096
$ 18,295,994 $ 15,015,317
$
127,303 $
—
730,386
—
388,600
67,088
1,313,377
3,077,457
446,000
3,523,457
4,836,834
420,245
333,339
350,518
31,000
1,135,102
—
385,000
385,000
1,520,102
—
—
201,825
201,875
2,703,050
2,732,006
10,590,340
10,525,279
13,495,215
13,459,160
$ 18,295,994 $ 15,015,317
20
IKONICS CORPORATION
STATEMENTS OF OPERATIONS
YEARS ENDED DECEMBER 31, 2016 AND 2015
NET SALES
COST OF GOODS SOLD
GROSS PROFIT
Year Ended
December 31,
2016
2015
$ 17,569,901 $ 17,562,066
11,332,991
11,417,474
6,236,910
6,144,592
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
5,611,849
5,263,372
RESEARCH AND DEVELOPMENT EXPENSES
647,065
660,402
INCOME (LOSS) FROM OPERATIONS
INTEREST EXPENSE
OTHER
INCOME (LOSS) BEFORE INCOME TAXES
INCOME TAX EXPENSE (BENEFIT)
(22,004)
220,818
(58,222)
—
11,165
4,189
(69,061)
225,007
(4,000)
90,000
NET INCOME (LOSS)
$
(65,061) $
135,007
INCOME (LOSS) PER COMMON SHARE:
Basic
Diluted
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
Basic
Diluted
See notes to financial statements.
$
$
(0.03) $
(0.03) $
0.07
0.07
2,018,649
2,018,649
2,018,253
2,018,591
21
IKONICS CORPORATION
STATEMENTS OF STOCKHOLDERS’ EQUITY
YEARS ENDED DECEMBER 31, 2016 AND 2015
Common Stock
Shares
Amount
Paid-in
Capital
Retained
Earnings
Additional
Total
Stock-
holders’
Equity
BALANCE AT DECEMBER 31, 2014
2,018,253 $ 201,825 $ 2,681,307 $ 10,455,333 $ 13,338,465
Net income
Stock based compensation and related tax
benefit
—
—
—
—
—
135,007
135,007
21,743
—
21,743
BALANCE AT DECEMBER 31, 2015
2,018,253
201,825
2,703,050
10,590,340
13,495,215
Net loss
Exercise of stock options and related tax
benefit
Stock based compensation and related tax
benefit
—
500
—
—
50
—
—
(65,061)
(65,061)
3,949
25,007
—
—
3,999
25,007
BALANCE AT DECEMBER 31, 2016
2,018,753 $ 201,875 $ 2,732,006 $ 10,525,279 $ 13,459,160
See notes to financial statements.
22
IKONICS CORPORATION
STATEMENTS OF CASH FLOWS
YEARS ENDED DECEMBER 31, 2016 AND 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating
activities:
Depreciation
Amortization
Stock based compensation
Net gain on sale of property, plant and equipment
Deferred income taxes
Loss on intangible asset abandonment
Changes in working capital components:
Trade receivables
Inventories
Prepaid expenses and other assets
Income tax receivable
Accounts payable
Accrued expenses
Net cash provided by operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant, equipment and construction in progress
Proceeds from sale of equipment
Purchases of intangibles
Purchases of short-term investments
Proceeds on sale of short-term investments
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from long-term debt
Payment of debt issuance costs
Payments on long-term debt
Proceeds from exercise of stock options
Net cash provided by financing activities
Year Ended
December 31,
2016
2015
$
(65,061)
$
135,007
760,772
33,768
25,007
(5,750)
61,000
—
(171,307)
133,633
(276,257)
36,831
310,141
74,170
916,947
659,528
25,040
21,743
—
18,000
45,873
(68,866)
510,845
752
60,873
49,064
8,202
1,466,061
(2,064,426)
21,000
(27,146)
(4,379,000)
1,133,000
(5,316,572)
(2,866,671)
—
(53,138)
(650,000)
2,416,000
(1,153,809)
3,415,000
(139,418)
(79,475)
3,765
3,199,872
—
—
—
—
—
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
(1,199,753)
312,252
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
2,248,466
1,936,214
CASH AND CASH EQUIVALENTS AT END OF PERIOD
$ 1,048,713
$
2,248,466
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Construction in progress included in construction accounts payable
$
—
$
333,339
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest
Cash received for tax refunds, net of $11,059 taxes paid in 2016
$
$
43,421
102,234
$
$
—
11,127
See notes to financial statements.
23
IKONICS CORPORATION
NOTES TO FINANCIAL STATEMENTS
YEARS ENDED DECEMBER 31, 2016 AND 2015
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of Business and Foreign Export Sales - IKONICS Corporation’s (the Company or IKONICS)
traditional business has been the development and manufacturing of high-quality photochemical imaging systems
for sale primarily to a wide range of printers and decorators of surfaces. Customers’ applications are primarily
screen printing and abrasive etching. These sales have been augmented with inkjet receptive films, ancillary
chemicals and related equipment to provide a full line of products and services to its customers. Leveraging these
technologies the Company is also diversifying and expanding its business to industrial markets. These efforts now
include the Company’s Advanced Material Solutions (AMS) business unit which uses the Company’s proprietary
process and photoresist film for the abrasive etching of composite materials, industrial ceramics, silicon wafers,
and glass wafers. The customer base for AMS is primarily the aerospace and electronics industries. Based on its
expertise in ultraviolet curable fluids and inkjet receptive substrates, the Company has also developed a patented
digital texturing technology (DTX) for putting patterns and textures into steel molds for the plastic injection
molding industry. The original equipment manufacturer (“OEM”) for the Company’s DTX technology is
primarily the automotive industry. Industrial inkjet printers, which are integral to the DTX system, are
manufactured and sold by a strategic partner. The Company’s business plan is to sell a suite of products including
consumable fluids and transfer films. For most markets these sales are direct to the mold maker. The DTX
technology is being expanded to prototyping where the Company’s technology offers a unique combination of
high definition and large format prints. The Company’s principal markets are throughout the United States. In
addition, the Company sells to Europe, Latin America, Asia, and other parts of the world. The Company extends
credit to its customers, all on an unsecured basis, on terms that it establishes for individual customers.
Foreign export sales approximated 25.7% of net sales in 2016 and 27.9% of net sales in 2015. The Company’s
trade receivables at December 31, 2016 and 2015 due from foreign customers were 23.6% and 21.4% of total
trade receivables, respectively. The foreign export receivables are comprised primarily of open credit
arrangements with terms ranging from 30 to 90 days. No single customer or foreign country represented greater
than 10% of net sales in 2016 or in 2015.
The Company considers events or transactions that occur after the balance sheet date but before the financial
statements are issued to provide additional evidence relative to certain estimates or to identify matters that require
additional disclosure.
A summary of the Company’s significant accounting policies follows:
Cash Equivalents - The Company considers all highly liquid debt instruments purchased with a maturity of three
months or less to be cash equivalents. Cash equivalents consist of money market funds in which the carrying
value approximates fair value because of the short maturity of these instruments. The money market fund invests
in United States dollar denominated securities that present minimal credit risk and consist of investments in debt
securities issued or guaranteed by the United States government or by United States government agencies or
instrumentalities, repurchase agreements fully collateralized by the United States Treasury, and United States
government securities.
Short-Term Investments - Short-term investments consist of fully insured certificates of deposit with original
maturities ranging from six to twelve months as of December 31, 2016. There were no short-term investments as
of December 31, 2015.
Trade Receivables — Trade receivables are carried at original invoice amount less an estimate made for doubtful
receivables based on a review of all outstanding amounts on an on-going basis. Management determines the
allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a
customer’s financial condition, credit history, and current economic conditions. Trade receivables are written off
when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received.
Accounts are considered past due if payment is not received according to agreed-upon terms.
24
A small percentage of the trade receivables balance is denominated in a foreign currency with no concentration in
any given country. At the end of each reporting period, the Company analyzes the receivable balance for
customers paying in a foreign currency. These balances are adjusted to each quarter or year-end spot rate in
accordance with Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”)
No. 830, Foreign Currency Matters. Foreign currency transactions and translation adjustments did not have a
significant effect on the Balance Sheets or the Statements of Operations, Stockholders’ Equity and Cash Flows
for 2016 and 2015.
Inventories - Inventories are stated at the lower of cost or market using the last-in, first-out (LIFO) method. If the
first-in, first-out (FIFO) cost method had been used, inventories would have been approximately $1,127,000 and
$1,232,000 higher than reported at December 31, 2016 and 2015, respectively. The inventory reserve for
obsolescence was $5,000 and $7,000 at December 31, 2016 and 2015, respectively. The major components of
inventories are as follows:
Raw materials
Work-in-progress
Finished goods
Reduction to LIFO cost
Total Inventories
Dec 31, 2016
Dec 31, 2015
$
1,438,471 $
355,208
1,319,856
(1,127,363)
1,640,098
375,229
1,336,707
(1,232,229)
$
1,986,172 $
2,119,805
Property, Plant and Equipment - Major expenditures extending the life of the property, plant and equipment are
capitalized. Repair and maintenance costs are expensed in the period in which they are incurred. Depreciation of
property, plant and equipment is computed using the straight-line method over the following estimated useful
lives:
Buildings
Machinery and equipment
Office equipment
Vehicles
Years
15-40
5-10
3-10
3
Intangible Assets — Intangible assets consist of patents and licenses. Intangible assets are amortized on a
straight-line basis over their estimated useful lives or agreement terms.
As of December 31, 2016, the remaining estimated weighted average useful lives of intangible assets are as
follows:
Patents
Licenses
Years
12.0
1.3
Impairment of Long-lived Assets — The Company reviews its long-lived assets, including property, plant and
equipment and intangible assets, for impairment when indicators of impairment are present and the undiscounted
cash flows estimated to be generated by those assets are less than the assets’ carrying amount. Any impairment
loss recorded is measured as the amount by which the carrying value of the assets exceeds the fair value of the
assets. The Company recognized a loss on abandonment of patents applied for of $46,000 in 2015. To date, the
Company has determined that no other loss of long-lived assets exists.
Fair Value of Financial Instruments — The carrying amounts of financial instruments, including cash and cash
equivalents, short-term investments, trade receivables, accounts payable, and accrued liabilities approximate fair
value due to the short maturities of these instruments. The fair value of long-term debt approximates carrying
25
value and has been estimated based on interest rates being offered for similar debt having the same or similar
remaining maturities and collateral requirements.
Revenue Recognition - The Company recognizes revenue on sales of products when title passes which can occur
at the time of shipment or when the goods arrive at the customer location depending on the agreement with the
customer. The Company sells its products to both distributors and end-users. Sales to distributors and end-users
are recorded based upon the criteria governed by the sales, delivery, and payment terms stated on the invoices
from the Company to the purchaser. In addition to transfer of title / risk of loss, all revenue is recorded in
accordance with the criteria outlined:
(a) persuasive evidence of an arrangement (principally in the form of customer sales orders and the Company’s
sales invoices, as generally there is no other formal agreement underlying the sale transactions);
(b) delivery and performance (evidenced by proof of delivery, e.g. the shipment of film and substrates with bill of
lading used for proof of delivery for FOB shipping point terms, and the carrier booking confirmation report
used for FOB destination terms. Once the finished product is shipped and physically delivered under the terms
of the invoice and sales order, the Company has no additional performance or service obligations to complete);
(c) a fixed and determinable sales price (the Company’s pricing is established and is not based on variable terms, as
evidenced in either the Company’s invoices or the limited number of distribution agreements; the Company
rarely grants extended payment terms and has no history of concessions); and
(d) a reasonable likelihood of payment (the Company’s terms are standard, and the Company does not have a
history of significant customer defaults or non-payment).
Sales are reported on a net basis by deducting credits, estimated normal returns and discounts. The Company’s
return policy does not vary by geography. The customer has no rotation or price protection rights and the
Company is not under a warranty obligation. Freight billed to customers is included in sales. Shipping costs are
included in cost of goods sold.
Deferred Taxes - Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for
deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are
recognized for taxable temporary differences. Temporary differences are the differences between the reported
amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance
when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets
will not be realized. The Company classifies deferred tax assets and liabilities as noncurrent. Deferred tax assets
and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The
Company follows the accounting standard on accounting for uncertainty in income taxes, which addresses the
determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the
financial statements. Under this guidance, the Company may recognize the tax benefit from an uncertain tax
position only if it is more likely than not that the tax position will be sustained on examination by taxing
authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements
from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of
being realized upon ultimate settlement. The guidance on accounting for uncertainty in income taxes also
addresses derecognition, classification, interest and penalties on income taxes, and accounting in interim periods.
Earnings Per Common Share (EPS) - Basic EPS is calculated using net income (loss) divided by the weighted
average of common shares outstanding. Diluted EPS is similar to Basic EPS except that the weighted average
number of common shares outstanding is increased to include the number of additional common shares, when
dilutive, that would have been outstanding if the potential dilutive common shares, such as those shares subject to
options, had been issued.
26
Shares used in the calculation of diluted EPS are summarized below:
Weighted average common shares outstanding
Dilutive effect of stock options
Weighted average common and common equivalent shares outstanding
2016
2015
2,018,649
-
2,018,649
2,018,253
338
2,018,591
At December 31, 2015, options to purchase 8,500 shares of common stock with a weighted average exercise price
of $17.16 were outstanding, but were excluded from the computation of common share equivalents because they
were anti-dilutive.
If the Company was in a net income position at December 31, 2016, 4,750 options with a weighted average
exercise price of $10.58 would have been included as part of the weighted average common and common
equivalent shares outstanding as the options would have been dilutive, while 11,418 options with a weighted
average exercise price of $15.99 would have remained excluded as the options were anti-dilutive.
Employee Stock Plan - The Company accounts for employee stock options under the provision of ASC 718,
Compensation — Stock Compensation.
Reclassification – For comparability, certain 2015 amounts related to deferred tax assets and liabilities have been
reclassified to conform with classifications adopted in 2016. The reclassification had no impact on net income or
stockholders’ equity.
Recent Accounting Pronouncements - In 2014, the FASB issued Accounting Standards Update (“ASU”) No.
2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties
about an Entity’s Ability to Continue as a Going Concern, intended to define management’s responsibility to
evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to
provide related footnote disclosures. ASU 2014-15 is effective for the Company in the year ended December 31,
2016, and interim periods beginning March 31, 2017, with early application permitted. The adoption of ASU
2014-15 did not have a material impact to the financial statements when implemented.
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers. ASU
2014-09 supersedes the revenue recognition requirements in Revenue Recognition (Topic 605), and requires
entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an
amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or
services. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers: Deferral of
the Effective Date, which defers the adoption of ASU 2014-09 to annual reporting periods beginning after
December 15, 2017, including interim reporting periods within that reporting period. Earlier application is
permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting
periods within that reporting period. The standard permits two methods of adoption: retrospectively to each prior
reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially
applying the guidance recognized at the date of initial application (the cumulative catch-up transition method).
The standard also requires expanded disclosures relating to the nature, amount, timing, and uncertainty of revenue
and cash flows arising from contracts with customers. Additionally, qualitative and quantitative disclosures are
required about customer contracts, significant judgments and changes in judgments, and assets recognized from
the costs to obtain or fulfill a contract. While the Company is still in the process of evaluating the effect of
adoption on its financial statements and is currently assessing its contracts with customers, the Company
anticipates that it will expand its financial statement disclosures in order to comply with the new standard. The
Company has established a timeline and process to evaluate the impact, transition and disclosure requirements of
the ASU and believes the timeline is sufficient to allow the Company to effectively implement the new standard.
The Company has not yet concluded on a transition method upon adoption, but plans to select a transition method
by the fourth quarter of 2017.
In 2015, the FASB issued ASU No. 2015-17, Income Taxes (Topic 740) Balance Sheet Classification of Deferred
Taxes, now requiring that deferred tax assets and liabilities be classified as noncurrent in a classified balance
sheet. The amendment takes effect for public entities for fiscal years beginning after December 15, 2016, with
27
early adoption available. The Company adopted this guidance for the quarter ended March 31, 2016 with
retrospective application and reclassified comparative periods for consistency. For 2015, a long-term deferred tax
liability of $580,000 has been netted with the current deferred tax asset of $195,000 for a net deferred tax liability
of $385,000.
In April 2015, the FASB issued ASU No. 2015-03, Interest-Imputation of Interest: Simplifying the Presentation of
Debt Issuance Costs. ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be
presented in the balance sheet as a direct deduction from the carrying amount of that debt liability rather than as
an asset. The standard is effective for fiscal periods beginning after December 15, 2015, and interim periods
therein and early application is permitted. Companies are required to adopt the standard retrospectively. The
standard will result in all deferred financing costs, excluding transaction costs incurred in connection with
securing revolving credit facilities, being deducted from long-term debt obligations in the Company’s balance
sheets. The Company adopted the provisions of ASU No. 2015-03 during 2016. The effect of the adoption did
not result in a change to equity or net income.
During February 2016, the FASB issued ASU No. 2016-02, Leases. ASU No. 2016-02 was issued to increase
transparency and comparability among organizations by recognizing all lease transactions (with terms in excess of
12 months) on the balance sheet as a lease liability and a right-of-use asset (as defined). ASU No. 2016-02 is
effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years,
with earlier application permitted. Upon adoption, the lessee will apply the new standard retrospectively to all
periods presented or retrospectively using a cumulative effect adjustment in the year of adoption. The Company is
currently assessing the effect that ASU No. 2016-02 will have on its financial statements.
In March 2016, the FASB issued ASU No. 2016-09, Compensation—Stock Compensation (Topic 718). This
standard makes several modifications to Topic 718 related to the accounting for forfeitures, employer tax
withholding on share-based compensation and the financial statement presentation of excess tax benefits or
deficiencies. ASU 2016-09 also clarifies the statement of cash flows presentation for certain components of share-
based awards. The standard is effective for interim and annual reporting periods beginning after December 15,
2016, although early adoption is permitted. The Company is currently assessing the effect that ASU No. 2016-09
will have on its financial statements.
Use of Estimates - The preparation of the financial statements in conformity with accounting principles generally
accepted in the United States of America requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ from those estimates. Significant estimates include the allowance for doubtful trade
receivables, the reserve for inventory obsolescence, and the valuation allowance for deferred tax assets.
2. INCOME TAXES
Income tax expense (benefit) for the years ended December 31, 2016 and 2015 consists of the following:
Current:
Federal
State
Deferred - Federal
2016
2015
$ (72,000) $ 62,000
10,000
72,000
18,000
$ (4,000) $ 90,000
7,000
(65,000)
61,000
28
The expected provision for income taxes, computed by applying the U.S. federal income tax rate of 34% in 2016
and 2015 to income (loss) before taxes, is reconciled to income tax expense as follows:
Expected provision for federal income taxes
State income taxes, net of federal benefit
Domestic manufacturers deduction
Non-deductible meals, entertainment, and life insurance
Research and development credit
Change in valuation allowance
Other
2016
2015
$ (23,000) $
7,000
-
27,000
(32,000)
15,000
2,000
(4,000) $
$
77,000
7,000
(6,000)
29,000
(30,000)
15,000
(2,000)
90,000
Net deferred tax liabilities consist of the following as of December 31, 2016 and 2015:
Deferred tax liabilities:
Accrued vacation
Inventories reserve
Allowance for doubtful accounts
Allowance for sales returns
Research and development credit carryforward
Accrued self-insured medical
Property and equipment
Intangible assets
Net operating loss
Other
Valuation allowance
Net deferred tax liabilities
2016
2015
$ 32,000 $ 26,000
126,000
5,000
37,000
45,000
1,000
(494,000)
(86,000)
-
-
(45,000)
$ (446,000) $ (385,000)
66,000
4,000
15,000
77,000
3,000
(499,000)
(92,000)
3,000
5,000
(60,000)
At December 31, 2016, the Company generated a federal credit carryforward for increasing research and
development costs of $17,000 which expires in 2036. The Company does not have any federal net operating loss
carryforwards due to current carryback potential to previous tax years. The Company generated state net
operating loss carryforwards in 2016 of $729,000 which begin expiring in 2026. The Company had state credit
carryforwards for increasing research and development costs as of December 31, 2016 and 2015 of $60,000 and
$45,000, respectively.
The valuation allowance balance of $60,000 and $45,000 at December 31, 2016 and 2015, respectively relates
entirely to Minnesota research and development credit carryforwards that the Company does not expect to utilize
and begin to expire in 2028. The change in the valuation allowance was $15,000 in 2016 and 2015, respectively.
It has been the Company’s policy to recognize interest and penalties related to uncertain tax positions in income
tax expense. As of December 31, 2016 and 2015, there was no liability for unrecognized tax benefits.
The Company is subject to federal and state taxation. The material jurisdictions that are subject to examination
by tax authorities primarily include Minnesota and the United States, for tax years 2013, 2014, 2015, and 2016.
3. INTANGIBLE ASSETS
Intangible assets consist of patents, patent applications, and licenses. Capitalized patent application costs are
included with patents. Intangible assets are amortized on a straight-line basis over their estimated useful lives or
terms of their agreement, whichever is shorter. The Company wrote off costs related to abandoned patent
applications of $46,000 in 2015. There were no abandonments or impairment adjustments to intangible assets
during the year ended December 31, 2016.
29
Intangible assets at December 31, 2016 and 2015 consist of the following:
December 31, 2016
December 31, 2015
Gross Carrying Accumulated Gross Carrying Accumulated
Amortization
Amortization
Amount
Amount
$
437,199 $ (103,238) $
50,000
(45,834)
$
487,199 $ (149,072) $
410,053 $ (81,248)
(42,709)
460,053 $ (123,957)
50,000
Amortized intangible assets:
Patents
License
Aggregate amortization expense:
For the years ended December 31
Estimated amortization expense for the years ending December 31:
2017
2018
2019
2020
2021
2016
2015
$ 25,115 $ 25,040
$ 26,000
24,000
22,000
22,000
22,000
In connection with the license agreement, the Company has agreed to pay royalties ranging from 3% to 5% on the
sales of products subject to the agreements. The Company incurred $12,000 of expense under these agreements
during 2016, and $15,000 during 2015 which are included in selling, general and administrative expenses in the
Statements of Operations.
4. RETIREMENT PLAN
The Company has established a salary deferral plan under Section 401(k) of the Internal Revenue Code. Such
deferrals accumulate on a tax-deferred basis until the employee withdraws the funds. The Company contributes
up to 5% of each eligible employee’s compensation. Total retirement expense for the years ended December 31,
2016 and 2015 was approximately $236,000 and $202,000, respectively.
5. SEGMENT INFORMATION
The Company’s reportable segments are strategic business units that offer different products and have varied
customer bases. There are five reportable segments: Domestic, Export, IKONICS Imaging, DTX and AMS.
Domestic sells screen printing film, emulsions, and inkjet receptive film to distributors located in the United
States and Canada. IKONICS Imaging sells photo resistant film, art supplies, glass, metal medium and related
abrasive etching equipment to end user customers located in the United States and Canada. AMS provides sound
deadening technology to the aerospace industry along with products and services for etched composites, ceramics,
glass and silicon wafers. DTX includes products and customers related to patented and proprietary inkjet
technology used for mold texturing and prototyping. Export sells primarily the same products as Domestic and
the IKONICS Imaging products not related to AMS or DTX. The accounting policies of the segments are the
same as those described in the summary of significant accounting policies included in Note 1.
30
Management evaluates the performance of each segment based on the components of divisional income, and does
not allocate assets and liabilities to segments except for trade receivables. Financial information with respect to
the reportable segments follows:
For the year ended December 31, 2016:
Net sales
Cost of goods sold
Gross profit (loss)
Selling, general, and
administrative*
Research and development*
Income (loss) from
operations
IKONICS
Imaging
Domestic
Export
$ 7,361,222 $ 4,508,577 $ 4,253,249 $
3,501,769
1,006,808
4,203,125
3,158,097
1,906,664
2,346,585
AMS
DTX
404,898 $ 1,041,955 $
162,376
242,522
1,559,057
(517,102)
Unalloc.
Total
— $ 17,569,901
11,332,991
—
6,236,910
—
1,396,266
—
650,513
—
1,052,823
—
144,970
—
419,469
—
1,947,808
647,065
5,611,849
647,065
$ 1,761,831 $
356,295 $ 1,293,762 $
97,552 $
(936,571) $
(2,594,873) $
(22,004)
For the year ended December 31, 2015:
Net sales
Cost of goods sold
Gross profit (loss)
Selling, general, and
administrative*
Research and development*
Income (loss) from
operations
Domestic
$
7,607,832 $
4,402,356
3,205,476
IKONICS
Imaging
Export
4,896,736 $ 3,952,929 $
3,767,589
1,129,147
1,854,519
2,098,410
DTX
476,286 $
254,863
221,423
AMS
628,283 $
1,138,147
(509,864)
Unalloc.
Total
— $ 17,562,066
11,417,474
—
6,144,592
—
1,337,069
—
580,173
—
988,823
—
174,525
—
347,298
—
1,835,484
660,402
5,263,372
660,402
1,868,407 $
548,974 $ 1,109,587 $
46,898 $
(857,162) $ (2,495,886) $
220,818
$
* The Company does not allocate all general and administrative expenses or any research and development expenses
to its operating segments for internal reporting.
Trade receivables by segment as of December 31, 2016 and December 31, 2015 were as follows:
Domestic
Export
IKONICS Imaging
DTX
AMS
Unallocated
Total
6. STOCK OPTIONS
Dec 31, 2016
Dec 31, 2015
$ 1,206,866 $
551,803
363,602
52,935
177,374
(16,079)
1,206,077
528,372
341,980
26,314
164,639
(102,188)
$ 2,336,501 $
2,165,194
The Company has a stock incentive plan for the issuance of up to 442,750 shares of common stock. The plan
provides for granting eligible participants stock options or other stock awards, as described by the plan, at prices
ranging from 85% to 110% of fair market value at date of grant. Options granted expire up to seven years after
the date of grant. Such options generally become exercisable over a three year period. A total of 104,239 shares
of common stock are reserved for additional grants of options under the plan as of December 31, 2016.
Under the plan, the Company charged compensation expense of $25,007 and $21,743 against income in 2016 and
2015, respectively.
31
As of December 31, 2016, there was approximately $33,000 of unrecognized compensation expense related to
unvested share-based compensation awards granted which is expected to be recognized over the next three years.
Proceeds from the exercise of stock options were approximately $3,800 for 2016. There was no exercise of stock
options in 2015.
The fair value of options granted during 2016 and 2015 was estimated using the Black-Scholes option pricing
model with the following assumptions:
Dividend yield
Expected volatility
Expected life of option
Risk-free interest rate
Fair value of each option on grant date
2016
0%
42.4%
Five Years
1.3%
$ 4.02
2015
0%
42.3% - 42.4%
Five Years
1.4% - 1.5%
$5.43 - $6.14
There were 4,500 options and 7,250 options granted during 2016 and 2015, respectively.
FASB ASC 718, Compensation — Stock Compensation specifies that initial accruals be based on the estimated
number of instruments for which the requisite service is expected to be rendered. Therefore, the Company is
required to incorporate a preexisting forfeiture rate based on the historical forfeiture experience and prospective
actuarial analysis, estimated at 3%.
A summary of the status of the Company’s stock option plan as of December 31, 2016 and changes during the
year then ended is presented below:
Outstanding at January 1, 2016
Granted
Exercised
Outstanding at December 31, 2016
Exercisable at December 31, 2016
Shares
Weighted
Average
Exercise
Price
15.47
10.75
7.53
14.40
15.41
12,168 $
4,500
(500)
16,168 $
6,417 $
The weighted-average grant date fair value of options granted was $4.02 and $5.92 for the years ended
December 31, 2016 and 2015, respectively. The total intrinsic value of stock options exercised was $2,160 for
the year ended December 31, 2016. No stock options were exercised in 2015.
7. CONCENTRATION OF CREDIT RISK
The Company maintains its cash balances primarily in two financial institutions. As of December 31, 2016, the
balance at one of the institutions exceeded the Federal Deposit Insurance Corporation coverage.
Trade receivables are financial instruments that also expose the Company to concentration of credit risk. The
large number of customers comprising the Company’s customer base and their dispersion across different
geographic areas limits such exposure. In addition, the Company routinely assesses the financial strength of its
customers and maintains an allowance for doubtful accounts that management believes will adequately provide
for credit losses.
8. LONG-TERM DEBT
On April 1, 2016, the Company entered into a financing agreement (the “Financing Agreement”) under which the
Duluth Economic Development Authority (the “Issuer”) agreed to sell $3,415,000 of its Tax Exempt Industrial
Revenue Bonds, Series 2016 (IKONICS Project) (the “Bonds”) to Wells Fargo Bank, National Association (the
“Bank”), and the Bank agreed to lend to the Company the proceeds received from the sale of the Bonds (the
“Loan”).
32
The closing of the sale of the Bonds occurred on April 29, 2016. The proceeds from the Loan were used to
finance the construction of a 27,300-square foot building as well as related equipment for use in the Company’s
manufacture of sound deadening technology used in the aerospace industry and products consisting of etched
composites, ceramics, glass and silicon wafers, to be located in Duluth, Minnesota (the “Project”).
The Loan requires monthly payments of approximately $18,000, including interest. The Loan bears interest at a
rate of 2.14% per year, payable monthly, and matures on April 1, 2041. Including debt costs of approximately
$139,000, the Loan’s effective interest rate is 2.77% per year.
The Loan is subject to mandatory purchase provisions, under which any owners of the Bonds (the “Owners”) may
tender the Bonds to the Issuer on April 1, 2021, which would result in the Company repaying the outstanding loan
principal and any outstanding accrued and unpaid interest to the Issuer at that time. If in the event the Bonds are
not repurchased on April 1, 2021, the Bonds shall be subject to the interest rate and redemption provisions set
forth in the associated covenant agreement.
Subject to limitations in the associated covenant agreement, the Company may cause a redemption of the Bonds,
in whole or in part, in authorized denominations at the redemption prices set forth in the Financing Agreement,
together with any accrued or unpaid interest to the date of redemption. The Bonds are also subject to redemption
in whole in the event of certain extraordinary events related to the Project.
The Company is subject to certain customary covenants set forth in the associated covenant agreement, including
a requirement that the Company maintain a debt service coverage ratio as of the end of each calendar quarter of
not less than 1.25 to 1.00 on a rolling four-quarter basis.
The remaining principal payments required under the agreement for years ended December 31, and the current
and long-term portion of the principal, are as follows:
2017
2018
2019
2020
2021
Thereafter
Total Principal
Less: Unamortized debt issuance costs
Less: Current portion
Long-term portion
$ 140,000
143,000
146,000
149,000
152,000
2,605,000
3,335,000
131,000
127,000
$ 3,077,000
In connection with the agreement, the Company incurred debt issuance costs of approximately $139,000 during
2016, which were deferred and are being amortized over the term of the Financing Agreement. Amortization of
debt issuance costs was approximately $9,000 for 2016 and is included in interest expense. Debt issuance costs
of $118,000 and $13,000 are netted against long-term debt and current portion of long-term debt, respectively
as of December 31, 2016. Amortization of debt costs is expected to be approximately $12,000 annually for each
of the next five years.
In addition to the $3,415,000 in indebtedness pursuant to the Loan, the Company has a bank line of credit
providing for borrowings of up to $2,050,000, expiring on May 31, 2017 that bears interest at 1.8 percentage
points over the 30-day LIBOR rate. The Company did not utilize this line of credit during 2016 or 2015 and
there were no borrowings outstanding as of December 31, 2016 and 2015. There are no financial covenants
related to the line of credit and the Company expects to obtain a similar line of credit when the current line of
credit expires.
Both the $3,415,000 financing pursuant to the Loan and the line of credit are collateralized by substantially all
assets of the Company.
33
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Not applicable.
Item 9A. Controls and Procedures
Disclosure Controls and Procedures. As of December 31, 2016, an evaluation was carried out under the supervision and
with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the
effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under
the Securities Exchange Act of 1934 (the “Exchange Act”)). Based upon that evaluation, the Chief Executive Officer and
the Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were
effective to ensure that information required to be disclosed by us in the reports that we file or submit under the
Exchange Act is recorded, processed, summarized and reported within the time periods specified in applicable rules and
forms.
Management’s Annual Report on Internal Control Over Financial Reporting. Our management is responsible for
establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-
15(f ) under the Exchange Act. Our internal control system is designed to provide reasonable assurance to our
management and board of directors regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles. Our internal control over
financial reporting includes those policies and procedures that:
Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and
dispositions of the assets of the Company;
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles, and that receipts and expenditures of
the Company are being made only in accordance with authorizations of management and directors of the
Company; and
Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or
disposition of the Company’s assets that could have a material effect on the financial statements.
Management assessed the effectiveness of our internal control over financial reporting as of December 31, 2016. In
making this assessment, management used the 2013 criteria set forth by the Committee of Sponsoring Organizations of
the Treadway Commission (COSO) in Internal Control — Integrated Framework. Based on management’s assessment
and those criteria, management believes that, as of December 31, 2016, the Company maintained effective internal
control over financial reporting.
This annual report does not include an attestation report of the Company’s registered public accounting firm regarding
internal control over financial reporting. Our management’s report of the effectiveness on the design and operation of
our internal control over financial reporting was not subject to attestation by the Company’s registered public accounting
firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only
management’s report in this annual report.
Changes in Internal Control Over Financial Reporting. There was no change in the Company’s internal control over
financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and Rule 15d-15(d) of the
Exchange Act that occurred during the period covered by this report and that has materially affected, or is reasonably
likely to materially affect, the Company’s internal control over financial reporting.
Item 9B. Other Information
None.
34
Item 10. Directors and Executive Officers of the Registrant
PART III
The information to be included in the Company’s definitive proxy statement for the 2017 Annual Meeting of
Shareholders under the captions “Election of Directors,” “Executive Officers” and “Section 16(a) Beneficial Ownership
Reporting Compliance” is incorporated by reference. The following information completes the Company’s response to
this Item 10.
The Company has adopted a code of ethics that applies to the Company’s Chief Executive Officer, Chief
Financial Officer, Controller and other employees performing similar functions. This code of ethics is filed as
Exhibit 14 to this report. The Company intends to satisfy the disclosure requirement under Item 5.05 of Form 8-K
regarding an amendment to, or a waiver from, this code of ethics by posting such information on its web site which is
located at www.ikonics.com.
Item 11. Executive Compensation
The information to be included in the Company’s definitive proxy statement for the 2017 Annual Meeting of
Shareholders under the captions “Election of Directors—Director Compensation,” “Summary Compensation Table,”
“Outstanding Equity Awards at Fiscal Year-End” and “Employment Contracts; Termination of Employment and
Change-In-Control Arrangements” is incorporated by reference.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information to be included in the Company’s definitive proxy statement for the 2017 Annual Meeting of
Shareholders under the captions “Security Ownership of Principal Shareholders and Management” and “Equity
Compensation Plan Information” is incorporated by reference.
Item 13. Certain Relationships and Related Transactions, and Director Independence
The information to be included in the Company’s definitive proxy statement for the 2017 Annual Meeting of
Shareholders under the caption “Election of Directors” is incorporated by reference. The Company has not engaged in
any transaction since the beginning of its last fiscal year and does not currently propose to engage in any transaction
required to be disclosed pursuant to Item 404 of Regulation S-K.
Item 14. Principal Accountant Fees and Services
The information to be included in the Company’s definitive proxy statement for the 2017 Annual Meeting of
Shareholders under the caption “Principal Accounting Firm Fees” is incorporated by reference.
Item 15. Exhibits and Financial Statement Schedules
(a)(1) The following financial statements of the Company are filed as part of this Annual Report on Form 10-K;
(i) Report of RSM US LLP, independent registered public accounting firm
(ii) Balance Sheets as of December 31, 2016 and 2015
(iii) Statements of Operations for the years ended December 31, 2016 and 2015
(iv) Statements of Stockholders’ Equity for the years ended December 31, 2016 and 2015
(v) Statements of Cash Flows for the years ended December 31, 2016 and 2015
(vi) Notes to the Financial Statements
35
(b) The following exhibits are filed as part of this Annual Report on Form 10-K for the fiscal year ended
December 31, 2016:
Exhibit
3.1
3.2
4
10.1*
10.2
10.3
14
23
24
31.1
31.2
32
101
Description
Restated Articles of Incorporation of Company, as amended. (Incorporated by reference to the like numbered Exhibit to
the Company’s Registration Statement on Form 10-SB filed with the Commission on April 7, 1999 (Registration
No. 000-25727)).
By-Laws of the Company, as amended. (Incorporated by reference to the like numbered Exhibit to the Company’s
Current Report on Form 8-K filed with the Commission on February 22, 2007 (File No. 000-25727)).
Specimen of Common Stock Certificate. (Incorporated by reference to the like numbered Exhibit to Amendment No. 1 to
the Company’s Registration Statement on Form 10-SB filed with the Commission on May 26, 1999 (Registration
No. 000-25727)).
IKONICS Corporation 1995 Stock Incentive Plan, as amended. (Incorporated by reference to the like numbered
Exhibit to the Company’s Annual Report on Form 10-K filed with the Commission on March 3, 2011 (File No. 000-
25727)).
Confidentiality Agreement, dated March 11, 2013, between the Company and Joseph R. Nerges. (Incorporated by
reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on March 13, 2013
(File No. 000-25727)).
Financing Agreement dated April 1, 2016 by and between Duluth Economic Development Authority, the
Company and Wells Fargo Bank, National Association. (Incorporated by reference to Exhibit 10.1 to the
Company’s Quarterly Report on Form 10-Q filed with the Commission on May 12, 2016 (File No. 000-
25727)).
Code of Ethics. (Incorporated by reference to the like numbered Exhibit to the Company’s Annual Report on Form 10-
KSB for the year ended December 31, 2003 (File No. 000-25727)).
Consent of Independent Registered Public Accounting Firm.
Powers of Attorney.
Rule 13a-14(a)/15d-14(a) Certifications of CEO.
Rule 13a-14(a)/15d-14(a) Certifications of CFO.
Section 1350 Certifications.
Interactive data files pursuant to Rule 405 of Regulation S-T.**
* Management contract or compensatory plan, contract or arrangement required to be filed as an exhibit to this Annual
Report on Form 10-K.
** In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to this Annual Report
on Form 10-K is deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the
Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities and Exchange Act of
1934, as amended, and otherwise is not subject to liability under those sections.
36
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on March 3, 2017.
SIGNATURES
IKONICS CORPORATION
By
/s/ William C. Ulland
William C. Ulland, Chairman, Chief Executive Officer
and President
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the
following persons on behalf of the registrant and in the capacities indicated on March 3, 2017.
/s/ William C. Ulland
William C. Ulland, Chairman, Chief Executive Officer
and President
(Principal Executive Officer)
/s/ Jon Gerlach
Jon Gerlach, Chief Financial Officer
and Vice President of Finance
(Principal Financial and Accounting Officer)
Marianne Bohren*
Gerald W. Simonson*
Lockwood Carlson*
David O. Harris*
Ernest M. Harper Jr.*
Darrell B. Lee*
Jeffrey D. Engbrecht*
Director
Director
Director
Director
Director
Director
Director
*William C. Ulland, by signing his name hereto, does hereby sign this document on behalf of each of the above named
Directors of the registrant pursuant to powers of attorney duly executed by such persons.
William C. Ulland, Attorney-in-Fact
/s/ William C. Ulland
37
INDEX TO EXHIBITS
Description
Restated Articles of Incorporation of Company, as amended
By-Laws of the Company, as amended.
Specimen of Common Stock Certificate
IKONICS Corporation 1995 Stock Incentive Plan, as amended
Confidentiality Agreement, dated March 11, 2013, between the
Company and Joseph R. Nerges
Financing Agreement dated April 1, 2016 by and between Duluth
Economic Development Authority, the Company and Wells Fargo
Bank, National Association.
Code of Ethics
Consent of Independent Registered Public Accounting Firm
Powers of Attorney
Rule 13a-14(a)/15d-14(a) Certifications of CEO
Rule 13a-14(a)/15d-14(a) Certifications of CFO
Section 1350 Certifications
Interactive data files pursuant to Rule 405 of Regulation S-T
Exhibit
3.1
3.2
4
10.1
10.2
10.3
14
23
24
31.1
31.2
32
101
Page
Incorporated by Reference
Incorporated by Reference
Incorporated by Reference
Incorporated by Reference
Incorporated by Reference
Incorporated by Reference
Incorporated by Reference
Filed Electronically
Filed Electronically
Filed Electronically
Filed Electronically
Filed Electronically
Filed Electronically
38
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements No. 333-92893, No. 333-129220, and No. 333-
161351 on Forms S-8 of IKONICS Corporation of our report dated March 3, 2017, relating to our audits of the financial
statements, which appear in this Annual Report on Form 10-K of IKONICS Corporation for the year ended
December 31, 2016.
/s/ RSM US LLP
EXHIBIT 23
Duluth, Minnesota
March 3, 2017
IKONICS CORPORATION
Powers of Attorney
EXHIBIT 24
The undersigned directors of IKONICS Corporation, a Minnesota corporation, do hereby make, constitute and
appoint William C. Ulland and Jon R. Gerlach, and either of them, the undersigned’s true and lawful attorneys-in-fact,
with power of substitution, for the undersigned and in the undersigned’s name, place and stead, to sign and affix the
undersigned’s name as such director of said Corporation to an Annual Report on Form 10-K or other applicable form,
and all amendments thereto, to be filed by said Corporation with the Securities and Exchange Commission, Washington,
D.C., under the Securities Act of 1934, as amended, with all exhibits thereto and other supporting documents, with said
Commission, granting unto said attorneys-in-fact, and either of them, full power and authority to do and perform any and
all acts necessary or incidental to the performance and execution of the powers herein expressly granted.
IN WITNESS WHEREOF, each of the undersigned have hereunto set their hands as of March 3, 2017.
/s/ William C. Ulland
William C. Ulland
/s/ Gerald W. Simonson
Gerald W. Simonson
/s/ Ernest M. Harper Jr.
Ernest M. Harper Jr.
/s/ Darrell B. Lee
Darrell B. Lee
/s/ David O. Harris
David O. Harris
/s/ Marianne Bohren
Marianne Bohren
/s/ Lockwood Carlson
Lockwood Carlson
/s/ Jeffrey D. Engbrecht
Jeffrey D. Engrecht
EXHIBIT 31.1
RULE 13a-14(a)/15d-14(a) CERTIFICATIONS OF CEO
I, William C. Ulland, certify that:
1. I have reviewed this annual report on Form 10-K of IKONICS Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in
Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under
our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being
prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with generally accepted accounting
principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by
this report based on such evaluation;
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the
registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial
reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the
equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report
financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the
registrant’s internal control over financial reporting.
Date: March 3, 2017
/s/ William C. Ulland
William C. Ulland
Chairman, Chief Executive Officer
and President
EXHIBIT 31.2
RULE 13a-14(a)/15d-14(a)/CERTIFICATIONS OF CFO
I, Jon Gerlach, certify that:
1. I have reviewed this annual report on Form 10-K of IKONICS Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in
Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under
our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being
prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with generally accepted accounting
principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by
this report based on such evaluation;
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the
registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial
reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the
equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report
financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the
registrant’s internal control over financial reporting.
Date: March 3, 2017
/s/ Jon Gerlach
Jon Gerlach
Chief Financial Officer
and Vice President of Finance
SECTION 1350 CERTIFICATIONS
EXHIBIT 32
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned certifies that this periodic
report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that
information contained in this periodic report fairly presents, in all material respects, the financial condition and results of
operations of IKONICS Corporation.
Date: March 3, 2017
Date: March 3, 2017
/s/ William C. Ulland
William C. Ulland
Chairman, Chief Executive Officer
and President
/s/ Jon Gerlach
Jon Gerlach
Chief Financial Officer
and Vice President of Finance
( This page has been left blank intentionally.)
Board of Directors
Corporate Officers
Lockwood Carlson
President
William C. Ulland
Chairman, President & CEO
Carlson Consulting Group
Minneapolis, MN
Director Since 2009
Ernest M. Harper Jr.
Chief Tax Officer (retired 2010)
General Mills, Inc.
Minneapolis, MN
Director Since 2012
David O. Harris
President
Ken Hegman
Chief Operating Officer
Claude Piguet
Executive Vice President
Jon Gerlach
Vice President, Finance, CFO,
Treasurer, and Secretary
Robert D. Banks
Vice President, International
David O. Harris, Inc.
Minneapolis, MN
Director Since 1965
Common Stock
IKONICS Corporation common stock is traded on the Nasdaq Capital Market
under the symbol IKNX. For investment and stock information contact:
Darrell B. Lee
Vice President, Chief Financial
Officer, Treasurer, Secretary (retired 2014)
MOCON, Inc.
Minneapolis, MN
Director Since 2012
Gerald W. Simonson
President
Omnetics Connector Corporation
Minneapolis, MN
Director Since 1978
William C. Ulland
Chairman, President & CEO
IKONICS Corporation
Duluth, MN
Director Since 1972
Marlanne Bohren
Executive Director
Western Lake Superior Sanitary District
Duluth, MN
Director Since 2016
Jon Gerlach
Chief Financial Officer
IKONICS Corporation
4832 Grand Avenue, Duluth, MN 55807
Phone: (218) 628-2217
email: jgerlach@ikonics.com
Transfer Agent
Wells Fargo Shareowner Services
PO Box 64854
St. Paul, MN 55164-0854
Shareholders with questions on stock holdings, transfer requirements
and address changes contact Wells Fargo Bank at: (800) 468-9716
Auditor
RSM US LLP
227 West First Street, Suite 700
Duluth, MN 55802
(218) 727-8253
Counsel
HANFT FRIDE
1000 U.S. Bank Place
130 W. Superior Street
Duluth, MN 55802
(218) 722-4766
Jeffrey D. Engbrecht
President & CEO
Clearwater Composites
Duluth, MN
Director Since 2016
Additional Financial Information
For a copy of the Form 10-K, as filed with the Securities and Exchange
Commission, and other financial information avail able at no charge to
stockholders, please contact:
Jon Gerlach
CFO
IKONICS Corporation
4832 Grand Avenue, Duluth, MN 55807
Phone: (218) 628-2217
email: jgerlach@ikonics.com
Annual Meeting
The Company’s annual meeting of shareholders will be held:
April 27, 2017 1:00 p.m.
Kitchi Gammi Club
831 E. Superior Street
Duluth, MN 55802
(800) 328-4261
www.ikonics.com
ISO 9001 Certifi ed | NASDAQ Listed: IKNX
170313